The regulatory landscape for hemp-derived compounds continues to evolve at an unprecedented pace, with terpenes gaining more prominence in international compliance frameworks.
For brands and manufacturers looking to distribute hemp terpene products across borders, understanding the regulatory pathways, notably GRAS (Generally Recognized as Safe) in the United States and Novel Food regulations in the EU and UK, is mission-critical.
This guide examines the regulatory environment for hemp terpenes across major markets, offering a roadmap for companies planning international distribution. With regulations tightening in some jurisdictions while opening up in others, strategic compliance planning has become a competitive advantage.
Key Takeaways
- Frameworks such as GRAS, Novel Food, and Natural Health Products differ in how they treat terpenes, their extraction methods, intended use, and benefit claims.
- Hemp terpenes marketed as flavorings may use established food additive routes, while those positioned for functional benefits face stricter regulatory scrutiny.
- Leading brands leverage parallel product development, thorough documentation, and market-specific regulatory intelligence to reduce compliance risks.
Regulatory Classification of Hemp Terpenes: Understanding the Fundamentals
Hemp/cannabis terpenes present unique regulatory considerations that differ substantially from cannabinoids and traditional flavor ingredients. Their regulatory status depends on several critical factors:
- Extraction method
- Intended use
- Concentration levels
- Marketing claims
Hemp-derived terpenes occupy a regulatory middle ground between conventional botanical extracts (which generally have established regulatory pathways) and novel hemp compounds like cannabinoids (which face stricter scrutiny). This creates challenges and opportunities for international brands.
The distinction between “hemp terpenes” and “cannabis terpenes” is not just semantic—it carries significant regulatory implications.
Hemp terpenes extracted from Cannabis sativa L. plants containing less than 0.3% THC (or 0.2% in the EU) potentially qualify for different regulatory treatment than those derived from higher-THC cannabis varieties. This classification forms the foundation for the different compliance strategies across markets.
Another talking point is the difference between terpenes used as flavoring agents versus those marketed for potential functional benefits. When positioned strictly as flavor components, hemp terpenes may use established pathways for food additives. However, additional regulatory requirements may apply when they are marketed with explicit or implied health claims.
For manufacturers like Terpene Belt Farms, which produces Native Cannabis Terpenes and Enhanced Natural blends, maintaining clear documentation of sourcing, extraction methods, and THC compliance is critical to navigating international regulations. These distinctions impact the regulatory pathways most appropriate for each product category.
United States: GRAS Pathways and FDA Considerations for Hemp Terpenes
In the United States, hemp terpenes face a complex regulatory landscape shaped by the 2018 Farm Bill, FDA oversight of food additives, and the GRAS framework. Understanding these interconnected regulations is vital for companies seeking to distribute terpene products in the American market.
The 2018 Farm Bill distinguished between hemp (defined as Cannabis sativa L. with ≤0.3% THC) and marijuana (cannabis with >0.3% THC), and effectively delisted hemp from the Controlled Substances Act.
While this legislation opened pathways for hemp cultivation and certain hemp products, it did not automatically establish food additive approval for all hemp-derived compounds. The FDA regulates hemp and hemp-derived substances in food, dietary supplements, and cosmetics.
Overall, the regulatory pathway for hemp terpenes varies based on intended use and marketing position.
GRAS Framework for Hemp Terpenes as Flavoring Agents
Certain hemp terpenes can exploit potential pathways through the GRAS framework when positioned strictly as flavoring agents. Terpenes like limonene, linalool, β-myrcene, α-pinene, and β-caryophyllene have established GRAS status when used in specified concentrations for flavoring purposes. This status applies to these compounds regardless of the source, not specifically to hemp-derived versions.
The situation is more complicated for complex terpene mixtures extracted from hemp. These terpene profiles may contain GRAS-listed terpenes and minor compounds without established status. For such complex mixtures, three potential GRAS approaches are possible:
- Self-Affirmed GRAS: Companies can assemble scientific evidence supporting safety for intended use and conduct independent expert panel reviews. While this offers faster market access, it carries a regulatory risk if later challenged by the FDA.
- GRAS Notification: Submitting a GRAS notice to the FDA provides greater regulatory certainty through the agency’s acknowledgment (though not approval). This approach may be necessary for hemp terpene producers targeting major food and beverage manufacturers to satisfy customer compliance requirements.
- GRAS Affirmation: This formal FDA approval process offers maximum regulatory certainty but requires substantial time and investment. Due to cost and timeline considerations, this pathway is rarely pursued for most hemp terpene applications.
Choosing between these approaches depends on risk tolerance, target customer requirements, and intended product positioning. In the current regulatory environment, companies pursuing the Self-Affirmed GRAS route should maintain robust safety documentation in anticipation of FDA scrutiny.
Hemp Terpenes Beyond Flavoring: Additional Considerations
Additional regulatory considerations apply to hemp terpenes marketed with benefit claims or in concentrations exceeding typical flavoring levels. The FDA has expressed ongoing concerns about hemp-derived products making health claims without appropriate substantiation or regulatory approval.
The FDA is particularly keen on products containing cannabinoids like CBD. Similarly, hemp terpenes marketed for their effects (rather than flavor) may face similar scrutiny, especially when marketing language suggests substantial physiological effects.
For companies developing products emphasizing the functional benefits of hemp terpenes, careful positioning and substantiation of claims are essential. It is strongly recommended to consult FDA regulatory counsel, as mischaracterization of products can trigger enforcement actions or market access barriers.
State-Level Variations for Hemp Terpenes
Individual states may impose additional restrictions and/or requirements for hemp-derived ingredients, adding complexity to the U.S. regulatory landscape. Some states have established hemp programs with mandatory testing, documentation, or registration requirements that exceed federal standards.
For cannabis brands distributing hemp terpene products nationally, monitoring state-level regulations is an essential compliance activity. In particular, states with developed cannabis regulatory frameworks often apply more requirements to hemp-derived compounds as well.
European Union: Novel Food Regulations and Hemp Terpene Pathways
The EU’s Novel Food Regulation (Regulation (EU) 2015/2283) is probably one of the most structured and stringent regulatory frameworks for hemp-derived ingredients globally. It is the primary mechanism governing market access for hemp terpenes in food applications across the EU, with important implications for manufacturers and distributors.
Under EU law, a “novel food” is defined as “food that was not consumed significantly in the EU before May 15, 1997.” Before they can be legally marketed, ingredients falling under this classification require pre-market authorization. This process entails submitting an application to the European Commission, followed by scientific evaluation by the European Food Safety Authority (EFSA).
For hemp terpenes, the Novel Food classification depends on the following factors:
Extraction Method Considerations
The extraction method significantly impacts regulatory classification in the EU context. Traditional extraction methods (like steam distillation) historically applied to hemp before 1997 may support arguments for non-novel status for the resulting terpene products.
However, newer techniques, such as CO₂ extraction, hydrocarbon extraction, or other advanced methods, may trigger Novel Food requirements if they produce extracts with different compositions or in higher concentrations than with traditional methods.
The focus on extraction methods creates crucial considerations for hemp terpene manufacturers. For international distribution, maintaining detailed documentation of extraction processes and developing parallel product lines using different techniques may be necessary to address EU market requirements.
Evolving EFSA Positions on Hemp Terpenes
The European Food Safety Authority has not officially addressed hemp-derived terpenes. However, several relevant precedents and ongoing evaluations provide guidance:
- Terpenes with an established history of use in food may be exempt from Novel Food requirements when used at traditional concentrations for flavoring purposes
- Complex terpene profiles or concentrates without an established history face a higher likelihood of Novel Food classification.
- The source of terpenes (hemp vs. other botanical sources) influences regulatory assessment.
- Products marketed for potential effects beyond flavoring face additional scrutiny
EFSA is expected to review several hemp extract applications, potentially establishing clearer precedents for hemp terpenes. Companies contemplating entry into EU markets should monitor these developments to inform their compliance strategy.
UK Novel Food Framework Post-Brexit
Following Brexit, the UK established a Novel Food framework that parallels but differs from the EU system in several ways. The UK Food Standards Agency (FSA) implemented a pathway for CBD products through a time-limited procedure that closed in March 2021.
For hemp terpenes, the UK approach remains aligned mainly with EU Novel Food principles, but with potential variations since UK food policy continues to develop independently. As such, brands targeting the UK market should:
- Monitor UK FSA announcements for hemp-specific guidance
- Consider UK-specific Novel Food applications if targeting this market (rather than relying solely on EU approvals)
- Maintain awareness of potential UK-EU regulatory variations that could impact compliance strategies
Additional International Markets: Canada, Australia, and Emerging Opportunities
Besides the US and EU markets, several additional international jurisdictions present opportunities and unique regulatory frameworks for hemp/cannabis terpene distribution.
Canadian Regulatory Framework for Hemp Terpenes
Canada’s regulatory approach to hemp terpenes could be advantageous for international brands, particularly through the Natural Health Products (NHP) framework and food additive regulations. Key aspects of the Canadian framework include:
Natural Health Products Regulations
For hemp terpenes marketed with health claims or functional benefits, the Natural Health Products pathway provides a structured regulatory mechanism. Hemp-derived terpenes may qualify for NHP licensing when:
- The source hemp meets Canadian industrial hemp regulations (≤0.3% THC)
- The extraction method is approved for NHP applications
- The product is supported by appropriate safety data
- Claims are substantiated according to NHP standards
This pathway offers a significant advantage compared to other markets, as it provides a legitimate route to market hemp terpenes for their potential beneficial effects rather than solely as flavoring agents.
Food and Flavor Applications
For food applications, terpenes used as flavoring agents follow regulatory principles similar to those of the US system. Many common hemp terpenes have been approved as food flavoring agents when used in appropriate concentrations.
However, complex hemp extract profiles require more detailed regulatory assessment. Health Canada has not established a policy addressing complex hemp terpene profiles, creating regulatory uncertainty for these products.
Australia/New Zealand: TGA and FSANZ Considerations
Australia and New Zealand present emerging opportunities for hemp terpene products, with distinct regulatory considerations under the Therapeutic Goods Administration (TGA) and Food Standards Australia New Zealand (FSANZ).
For hemp terpenes marketed as ingredients in therapeutic goods, the TGA regulates access through the following frameworks:
- Listed medicines (lower risk) pathway for certain applications
- Registered medicines pathway for products making specific therapeutic claims
- Schedule 4 (Prescription only) or Schedule 3 (Pharmacist only) classifications for certain cannabis compounds
For food applications, FSANZ oversees a Novel Food framework similar in concept to the EU system. This framework requires pre-market approval for ingredients without an established history of consumption.
A notable development is Australia’s potential reclassification of certain cannabis compounds, which could impact regulatory approaches to hemp terpenes. Companies targeting the Australian market should monitor these developments closely.
Emerging Markets: Latin America, Asia, and Beyond
Emerging markets present expansion opportunities for hemp terpene products, though with varying regulatory clarity:
- Latin America: Countries including Colombia, Brazil, and Mexico are developing regulatory frameworks for cannabis-derived compounds, with potential pathways for hemp terpenes in therapeutic and food applications.
- Asia: While much of Asia maintains restrictive policies on cannabis generally, markets like Thailand, South Korea, and Japan have established specific pathways for certain hemp-derived compounds. These frameworks may extend to terpene products with appropriate positioning and compliance documentation.
- Africa: Selected markets like South Africa and Morocco are developing regulatory approaches to cannabis-derived ingredients, potentially opening pathways for compliant hemp terpene products.
Regulatory assessments are essential for international distribution strategies targeting these emerging markets, as frameworks continue to evolve rapidly and may not align with established ones (US or EU).
Strategic Approaches to Global Compliance for Hemp Terpene Products
Navigating the complex global regulatory landscape for hemp terpenes requires integrated planning that addresses technical compliance requirements and practical business considerations. Strategic frameworks can help companies develop effective international distribution models:
1. Parallel Product Development for Regional Compliance
Rather than attempting to create single products that satisfy all global requirements, cannabis brands can develop parallel product lines optimized for specific regional regulations:
- US-focused products designed for GRAS compliance with appropriate documentation
- EU/UK-focused products with extraction methods and documentation supporting Novel Food compliance
- Market-specific formulations addressing unique requirements in Canada, Australia, or other target regions
While requiring additional product development resources, this approach is more efficient than attempting to force a single product through disparate regulatory frameworks.
Our Enhanced Natural Terpenes exemplify this parallel development approach, with specific versions optimized for different regulatory environments while maintaining consistent sensory and functional characteristics.
2. Documentation Hierarchies for International Compliance
Establishing comprehensive documentation systems supports efficient regulatory submissions. Essential documentation components can include:
- Agricultural compliance records: Documentation of hemp sourcing, THC testing, and cultivation practices
- Process validation: Detailed extraction methodology documentation with established parameters and controls
- Compositional analysis: Comprehensive terpene profiling with consistent methodology across batches
- Safety assessments: Toxicological evaluations appropriate for intended use levels and applications
- Stability data: Evidence of consistent composition throughout shelf life under various conditions
3. Regulatory Intelligence Monitoring Systems
Given the rapidly evolving nature of hemp regulations, establishing systematic monitoring of regulatory developments is essential for maintaining compliance and identifying new opportunities. Components of effective monitoring may include:
- Regular review of regulatory agency communications in target markets
- Participation in industry associations engaged with hemp regulations
- Relationship development with regulatory consultants specializing in target regions
- Scenario planning for potential regulatory changes based on market signals
4. Strategic Market Sequencing for International Expansion
Rather than pursuing simultaneous global distribution, strategically sequencing market entry based on regulatory complexity and opportunity size is more efficient. Typical sequencing approaches include:
- Initial markets with established regulatory frameworks and significant opportunity size (e.g., US, Canada, and select EU countries)
- Secondary targets requiring moderate adaptation of existing compliance documentation
- Long-term opportunity markets requiring substantial investment in regulatory development
This phased approach allows companies to establish revenue streams from more accessible markets while developing longer-term regulatory strategies for more complex regions.
Partnering with experienced hemp ingredient suppliers who maintain regulatory documentation for multiple markets can significantly reduce compliance burdens for companies seeking to accelerate market access.
Our white-label program provides access to 100% cannabinoid-free cannabis terpenes. You can also request terpene sample packs for evaluation before buying in bulk under our Wholesale program.
2025 Outlook: Emerging Regulatory Trends for Hemp Terpenes
The regulatory landscape for hemp terpenes continues to evolve, with several trends emerging in 2025 that will shape international distribution opportunities going forward:
Increasing Distinction from Cannabinoid Regulations
Regulatory authorities increasingly recognize the differences between hemp-derived cannabinoids and terpenes, creating more defined pathways for terpene products. This trend is particularly evident in:
- US FDA communications distinguishing flavor components from cannabinoids
- European regulatory frameworks developing separate considerations for terpenes versus cannabinoids
- International standards organizations working to establish specific frameworks for terpene evaluation
This creates streamlined compliance pathways for hemp terpene products positioned appropriately without the full regulatory burden applied to cannabinoids.
Harmonization Initiatives for International Standards
Several international standards initiatives seek to create more harmonized approaches to hemp-derived ingredients, including:
- ISO/TC 34/SC 7 working group on cannabis standards
- AOAC cannabis analytical standards development
- WHO Expert Committee Review on cannabis compounds
While global harmonization remains distant, these initiatives may reduce compliance burdens for multi-market distribution by establishing recognized testing methodologies and safety assessment approaches.
Shifting Focus to Processing Methods and Standards
Regulatory frameworks increasingly focus on extraction and processing methods rather than hemp ingredients as a general category. This trend creates opportunities for companies employing traditional or established extraction technologies with documented safety profiles.
Demonstrating process standardization and validation will likely be critical in regulatory submissions across markets in 2025 and beyond. Companies that develop comprehensive process documentation will gain advantages in multi-market compliance.
Co-Development of Regulatory Frameworks with Industry
In several jurisdictions, regulatory authorities engage with industry stakeholders to develop appropriate frameworks for hemp-derived ingredients. Such collaborative approaches create more practical regulatory pathways based on actual industry practices and technical capabilities.
Moreover, companies that participate in trade associations, standards development organizations, and regulatory engagement initiatives gain valuable intelligence and potential influence in framework development.
Conclusion: Developing Your International Compliance Roadmap
Navigating global regulations for hemp terpenes requires systematic planning, market-specific strategies, and robust technical documentation. For companies seeking global distribution, these practical steps can establish an effective compliance foundation:
- Conduct comprehensive regulatory assessments for priority markets to identify specific requirements and potential barriers
- Develop parallel product specifications optimized for regional requirements when necessary
- Establish documentation systems that support multi-market submissions
- Build relationships with regulatory consultants specializing in key target markets
- Participate in industry initiatives developing standards for hemp-derived ingredients
- Consider strategic partnerships with experienced suppliers with existing regulatory frameworks
Implementing these approaches within a strategic market development plan can transform regulatory complexities into a competitive advantage. Companies that navigate these diverse frameworks will capture significant opportunities in the expanding global market for hemp terpene products.
At Terpene Belt Farms, we specialize in navigating these complex regulatory environments, offering compliant, Fresh Never Frozen® terpene products.
Contact our technical team for a consultation on compliance-optimized product formulations designed for your target markets.
Frequently Asked Questions
Do Hemp-Derived Terpenes Need GRAS Status to Be Sold in the U.S. as Flavoring Agents?
Yes. While individual terpenes like limonene or linalool already have GRAS status when used within approved limits, complex hemp terpene blends often require companies to pursue Self-Affirmed GRAS or file a GRAS Notification with the FDA. Proper documentation and safety data are essential.
Can I Use the Same Terpene Formulation for Global Distribution?
Not usually. Because compliance requirements vary significantly between regions (e.g., GRAS in the U.S., Novel Food in the EU, and NHPs in Canada), developing parallel product lines tailored to regional regulations is often more effective than a one-size-fits-all approach.
What Factors Influence Terpene Regulation in the EU and UK?
The extraction method, source plant, history of use, and product claims all play a major role. Traditional steam-distilled terpenes used solely for flavoring may avoid Novel Food classification, while advanced extraction methods or functional claims could trigger pre-market authorization requirements.
How Can Companies Stay Ahead of Evolving Global Terpene Regulations?
Companies should invest in regulatory intelligence systems, robust documentation practices, and strategic market sequencing. Partnering with regulatory experts and suppliers experienced in multi-market compliance, like Terpene Belt Farms, can significantly streamline the process.
Sources Cited
AOAC cannabinoid standard in USDA guidelines. (2019, November 12). AOAC INTERNATIONAL. https://www.aoac.org/news/aoac-cannabinoid-standard-in-usda-guidelines/
Bērziņš , A. (2021, December 16). DRAFT Programming Document 2023-2025: Science, Safe food, Sustainability. In European Food Safety Authority (pp. 9–169). EFSA. https://www.efsa.europa.eu/sites/default/files/event/mb-20211216/C06.draft-SPD-2023-2025-4.mb211216-a3.pdf
CBD Products Linked to Novel Food Applications. (2023, October 12). Food Standards Agency. https://www.food.gov.uk/business-guidance/cbd-products-linked-to-novel-food-applications
FDA regulation of cannabis and cannabis-derived products, including cannabidiol (CBD). (2024, July 16). U.S. Food and Drug Administration. https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
Generally Recognized as Safe (GRAS). (2023, October 17). U.S. Food and Drug Administration. https://www.fda.gov/food/food-ingredients-packaging/generally-recognized-safe-gras
Hemp Farming Act of 2018, 5485, House of Representatives (2018). https://www.congress.gov/bill/115th-congress/house-bill/5485/all-info
IWA 37-3:2022. Safety, Security and Sustainability of Cannabis Facilities and Operations. (2022, October). International Standards Organization. https://www.iso.org/standard/84025.html
Natural Health Product Regulation in Canada: Overview. (2024, May 17). Canada.Ca. https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/regulation.html
Safe Food for Life. (n.d.). Food Standards. Australia. New Zealand. Retrieved May 8, 2025, from https://www.foodstandards.gov.au/
Therapeutic Goods Administration (TGA). (2021, December 17). Australian Government | Department of Health, Disability and Aging. https://www.tga.gov.au/
Walsh, J., Jelsma, M., Blickman, T., & Bewley-Taylor, D. (2019, March 19). The WHO’s first-ever critical review of cannabis. Transnational Institute. https://www.tni.org/en/publication/the-whos-first-ever-critical-review-of-cannabis
What is Novel Food? (n.d.). EU Health & Food Safety. Retrieved May 27, 2025, from https://food.ec.europa.eu/food-safety/novel-food_en
Zormpas, A., Mitoula, V., Marchese, E., Pastor, P. M., Ferrer, M. V., Salvatore, S., Linares, A. G., Brocca, D., & Bocca, V. (2025). Chemical monitoring reporting guidance: 2025 data collection. EFSA Supporting Publications, 22(1). https://doi.org/10.2903/sp.efsa.2025.en-9245
